J Braun Selected Research

Necrosis

03/2008	Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response.
06/2006	Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases.
12/2005	Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab.
10/2005	Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab.
06/2003	Up regulation of the production of tumour necrosis factor alpha and interferon gamma by T cells in ankylosing spondylitis during treatment with etanercept.
11/2000	Treatment of spondyloarthropathies with antibodies against tumour necrosis factor alpha: first clinical and laboratory experiences.
04/2000	Response to methotrexate in early rheumatoid arthritis is associated with a decrease of T cell derived tumour necrosis factor alpha, increase of interleukin 10, and predicted by the initial concentration of interleukin 4.

Articles by Research Topic

Disease

43	Ankylosing Spondylitis 09/2008 - 06/2000
7	Necrosis 03/2008 - 04/2000
5	Rheumatoid Arthritis 01/2008 - 04/2000
3	Syndrome 03/2008 - 01/2002
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2007 - 10/2001
2	Pneumonia (Pneumonitis) 01/2006 - 02/2001
2	Crohn Disease (Crohn's Disease) 07/2001 - 01/2000
2	Reactive Arthritis (Reiter Disease) 12/2000 - 02/2000
1	Infection 09/2008
1	Ankylosis 09/2008
1	Spinal Diseases (Disease, Spinal) 04/2008
1	Hemorrhagic Shock 02/2007
1	Back Pain (Backache) 09/2006
1	Inflammation 12/2005
1	Anterior Uveitis 08/2005
1	Thrombophilia 05/2005
1	Epilepsy (Aura) 05/2003
1	Bacterial Pneumonia 01/2003
1	Cystic Fibrosis (Mucoviscidosis) 11/2002
1	Mixed Connective Tissue Disease (MCTD) 01/2002
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2002
1	B-Cell Lymphoma (Lymphoma, B Cell) 06/2001
1	Type 2 Diabetes Mellitus (MODY) 02/2001
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2001
1	Pulmonary Hypertension (Ayerza Syndrome) 10/2000
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2000
1	Hyperalgesia 09/2000
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2000
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2000
1	Genetic Predisposition to Disease (Genetic Predisposition) 03/2000
1	Ulcerative Colitis 02/2000

Drug/Important Bio-Agent (IBA)

19	infliximab (Remicade)FDA Link 04/2008 - 06/2000
11	TNFR-Fc fusion protein (etanercept)FDA Link 03/2008 - 06/2003
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2007 - 06/2000
3	Methotrexate (Mexate)FDA LinkGeneric 01/2008 - 04/2000
3	AntigensIBA 05/2002 - 02/2000
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 03/2008 - 08/2006
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 09/2006 - 04/2002
2	RadiumIBA 05/2006 - 04/2001
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2006 - 01/2003
2	Interleukin-10 (Interleukin 10)IBA 01/2003 - 04/2000
2	Membrane Proteins (Integral Membrane Proteins)IBA 10/2001 - 06/2001
2	CytokinesIBA 02/2001 - 08/2000
2	AntibodiesIBA 11/2000 - 01/2000
1	adalimumab (Humira)FDA Link 09/2008
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2008
1	Biological Markers (Surrogate Marker)IBA 04/2008
1	Vasopressins (Vasopressin)IBA 02/2007
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2006
1	leflunomide (Arava)FDA LinkGeneric 01/2005
1	pamidronate (APD)FDA LinkGeneric 08/2003
1	Aggrecans (Aggrecan)IBA 07/2003
1	Interferon-gamma (Interferon, gamma)IBA 06/2003
1	Valproic Acid (Valproate, Semisodium)FDA LinkGeneric 05/2003
1	human DNASE1 protein (dornase alfa)FDA Link 11/2002
1	Metalloproteases (Metalloproteinases)IBA 11/2002
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2002
1	Carbon MonoxideIBA 01/2002
1	Prednisolone (Predate)FDA LinkGeneric 01/2002
1	Bacterial Proteins (Bacterial Protein)IBA 07/2001
1	Codon (Codons)IBA 02/2001
1	Atovaquone (Mepron)FDA Link 01/2001
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2001
1	Iloprost (Ventavis)FDA Link 10/2000
1	Capsaicin (Zostrix)IBA 09/2000
1	Mexiletine (Mexitil)FDA LinkGeneric 09/2000
1	Interleukin-4 (Interleukin 4)IBA 04/2000
1	HLA-DRB1 antigen (HLA DRB1)IBA 03/2000
1	Calcitriol Receptors (Calcitriol Receptor)IBA 03/2000
1	Chaperonin 60IBA 02/2000
1	Histones (Histone)IBA 02/2000
1	MannansIBA 01/2000

Therapy/Procedure

1	Aftercare (After-Treatment) 04/2008
1	Transplants (Transplant) 05/2005
1	Transplantation (Transplant Recipients) 05/2005